A Study of U-500 Insulin (LY041001) in Participants With Type 2 Diabetes

Summary

The purpose of this two-part study is to measure how much of the study drug gets into the blood stream and how long it takes the body to get rid of it. In Part A, each participant will receive two treatments, a single dose and a single dose with continuous infusion of U-500R insulin, both administered just under the skin. Participants who complete Part A will continue into Part B where they will be assigned to 1 of 2 treatments with U-500R insulin, injected either twice or three times daily under the skin for 5-10 days. This study can last from 7-14 weeks including initial screening and follow up.

Timeline

Start

2016-01-12

Primary completion

2017-05-25

Completion

2017-05-25

Drugs

Indications